These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1195663)

  • 1. [Perimembranous glomerulonephritis after treatment with D-penicillamine. Report on 31 cases (author's transl)].
    Gärtner HV; Neild GH; Bohle A; Hallauer W; Hoppe-Seyler G; Lüttgen FM; Schollmeyer P
    Klin Wochenschr; 1975 Sep; 53(17):835-7. PubMed ID: 1195663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine induced membranous glomerulonephritis.
    Neild GH; Gärtner HV; Bohle A
    Scand J Rheumatol Suppl; 1979; (28):79-90. PubMed ID: 287195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nephrotic syndrome presumable caused by an complex glomerulonephritis (author's transl)].
    Seelig HP; Seelig R; Fischer K; Maurer R; Safer A; Schnitzlein W
    Res Exp Med (Berl); 1977 Apr; 169(1):35-55. PubMed ID: 141075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal glomerulitis due to penicillamine.
    Hayslett JP; Bensch KG; Kashgarian M; Rosenberg LE
    Lab Invest; 1968 Oct; 19(4):376-81. PubMed ID: 5699118
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiglomerular basement membrane glomerulonephritis following D-penicillamine-associated nephrotic syndrome.
    Bindi P; Gilson B; Aymard B; Noël LH; Wieslander J
    Nephrol Dial Transplant; 1997 Feb; 12(2):325-7. PubMed ID: 9132654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 7. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
    Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
    J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W; Gärtner HV; Kronenberg KH; Manz G
    Schweiz Med Wochenschr; 1974 Mar; 104(12):434-8. PubMed ID: 4820540
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 10. [Penicillamine-induced glomerulonephritis].
    Koall W; Mampel E
    Z Urol Nephrol; 1977 Jan; 70(1):13-7. PubMed ID: 848141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal renal vasculitis and minimal change glomerulonephritis complicating treatment with penicillamine. Report on two cases.
    Falck HM; Törnroth T; Kock B; Wegelius O
    Acta Med Scand; 1979; 205(1-2):133-8. PubMed ID: 760401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extramembranous glomerulonephritis in children: report of 50 cases.
    Habib R; Kleinknecht C; Gubler MC
    J Pediatr; 1973 May; 82(5):754-66. PubMed ID: 4572936
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recovery of normal ultrastructure in 2 cases of primary glomerulonephritis with diffuse extra-membranous deposits].
    Bariéty J; Samarcq P; Lagrue G; Fritel D; Milliez P
    Presse Med (1893); 1968 Nov; 76(46):2179-82. PubMed ID: 4888396
    [No Abstract]   [Full Text] [Related]  

  • 16. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature.
    Karpinski J; Jothy S; Radoux V; Levy M; Baran D
    Am J Nephrol; 1997; 17(6):528-32. PubMed ID: 9426850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.
    Ntoso KA; Tomaszewski JE; Jimenez SA; Neilson EG
    Am J Kidney Dis; 1986 Sep; 8(3):159-63. PubMed ID: 3752071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranous glomerulopathy associated with captopril therapy.
    Textor SC; Gephardt GN; Bravo EL; Tarazi RC; Fouad FM; Tubbs R; McMahon JT
    Am J Med; 1983 Apr; 74(4):705-12. PubMed ID: 6340493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous glomerulopathy and nephrotic syndrome after captopril therapy.
    Sturgill BC; Shearlock KT
    JAMA; 1983 Nov; 250(17):2343-5. PubMed ID: 6355523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of D-penicillamine administration to rats, induction of renal changes: preliminary communication.
    Batsford SR; Rohrbach R; Riede UN; Sandritter W; Kluthe R
    Clin Nephrol; 1976 Sep; 6(3):394-7. PubMed ID: 991466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.